centered on the tereceptide molecule;

The gathering of pharmacies all over Iran in the third prime event.

The third prime event was organized by Dr. Obidi's pharmaceutical company, focusing on the "terzapotide molecule" and with the simultaneous presence of 3,000 pharmacists, owners and operators of pharmacies in 23 districts in Israel. In its 80th year of operation, Dr. Obidi Pharmaceuticals released the drug Tirazeptide under the brand name ZCorpa in two forms: an auto-injector and a pre-filled pen. Holding the Prime training course is part of Dr. Obidi's pharmaceutical activity to provide comprehensive information regarding the correct use of tiraceptide after the release of ZCorpa. Click to read the full text of the news.